Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.
about
Successful treatment of extensively drug-resistant Acinetobacter baumannii peritoneal dialysis peritonitis with intraperitoneal polymyxin B and ampicillin-sulbactamThe Current State of Peritoneal DialysisEffects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: a multicenter registry studyEscherichia coli Peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center.Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysisThe effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study.Acinetobacter peritoneal dialysis peritonitis: a changing landscape over timeErtapenem pharmacokinetics and pharmacodynamics during continuous ambulatory peritoneal dialysis.The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial.Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis.Is transition between peritoneal dialysis and hemodialysis really a gradual process?Citrobacter peritoneal dialysis peritonitis: rare occurrence with poor outcomesSerratia marcescens Peritonitis in a Diabetic Patient Receiving Continuous Ambulatory Peritoneal Dialysis.Is female sex really a risk factor for infectious death in peritoneal dialysis?The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis.Infectious complications in dialysis--epidemiology and outcomes.Intraperitoneal meropenem for peritoneal dialysis peritonitis with Serratia marcescens immediately on commencing dialysisContinuous Quality Improvement Initiatives to Sustainably Reduce Peritoneal Dialysis-Related Infections in Australia and New Zealand.The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis.Peritoneal dialysis-related peritonitis: challenges and solutions.
P2860
Q28271359-10DC9F20-7D27-4337-99C1-0322046A5CCAQ30243902-3AF60FDB-F187-4BFB-9003-E7AA7D755997Q30560814-8168E551-F999-42D8-A311-D5B7A4D6DDF3Q33660340-9092D45B-4AAC-4207-8A9F-B97A8D856C68Q34182921-15F925DA-3E07-4DA7-9539-608902B3E7C7Q34306126-835FC428-27F6-418E-B839-C51770315E8EQ34338469-5F9EC43E-615C-48DC-829A-5F3C0053E8AEQ35689411-0C9E3475-C385-4BE6-B937-71C71BE5BEA4Q36474236-4EAAD68E-804D-4EBA-9B72-E187EBCE9DCAQ36474262-4158D730-20D5-4554-A800-53D470047E23Q37000691-013940E7-2BA7-4C24-8E63-D923514243FDQ37022259-9193C228-82DF-49F6-B806-AF249F21BA87Q37192096-BB5C88B3-2B0B-4D88-8770-2D7F47F5B5EFQ37232259-5C8793CC-1963-4DD7-9D5F-A27E592E7A47Q37669439-DC44AEF7-A956-4C99-B5DC-345ACC428AFFQ37969996-2345ED0A-82BF-4C18-9A51-FA90312D77A9Q38616285-E866B87A-DD09-4D98-9C59-804D18C0CE5EQ40530036-DC5ACD19-AF97-47FC-8D69-FAC44C91EA65Q41082058-90B61B61-8F8B-4114-99C1-180CCA676066Q42104270-B75BB84C-6C0D-4A12-9618-05A25C77C914Q47786464-1D859A30-2D9F-4F71-B295-03BC5EF1FF35Q55399642-DB773723-5DEB-4E49-9FDA-A4EFF159FBD7
P2860
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.
@en
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.
@nl
type
label
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.
@en
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.
@nl
prefLabel
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.
@en
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.
@nl
P2093
P50
P356
P1433
P1476
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis
@en
P2093
Elizabeth M Jarvis
Fiona G Brown
Kathryn J Wiggins
Kym M Bannister
Stephen P McDonald
P2888
P304
P356
10.1038/KI.2010.149
P407
P577
2010-05-26T00:00:00Z